Biotech | April 03, 2022
Dr. Reddy's and MediCane Health launch medical cannabis in Germany
The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021
The launch of medical cannabis products resulted from an agreement between the two companies signed in 2021
The Cidmus brand shall be affixed on the pharmaceutical composition comprising a combination of Valsartan and Sacubitril (currently under Novartis patent) which is indicated for heart failure patients with reduced ejection fraction
Phablecare closed this acquisition for an undisclosed sum, betting on the start-up's holistic approach to Type 1 Diabetes management
World-leading companies, as well as small innovative research groups, regularly partner with Medanex for their outstanding cardiovascular services and timely, efficacious study outcomes.
The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic
The enhanced portfolio includes the Scenaria View, Supria series, The Echelon Smart and Arietta series
Data to establish the safety profile and human dose of vaccine candidate
Manipal Hospitals partners with ConnectedLife, leveraging Fitbit wearable technology, for Continuity of Care Post-High-Risk Surgeries built with Google Cloud
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
Tapestri Platform powers Nature Cardiovascular Research publication that identifies two somatic mutations associated with sporadic brain blood vessel disorder
Subscribe To Our Newsletter & Stay Updated
